Q2 2024 |
5 |
$4.71B |
+$602M |
$0 |
+$602M |
CERE, SGRY, WAY, AVAH, ADV
|
13F-HR |
8/12/2024, 01:30 PM |
Q1 2024 |
4 |
$4.48B |
$0 |
$0 |
|
CERE, SGRY, AVAH, ADV
|
13F-HR |
5/15/2024, 10:30 AM |
Q4 2023 |
4 |
$4.61B |
+$232M |
-$266M |
-$33.2M |
CERE, SGRY, AVAH, ADV
|
13F-HR |
2/13/2024, 04:30 PM |
Q3 2023 |
5 |
$3.12B |
|
-$1.99B |
-$1.99B |
SGRY, CERE, AVAH, ADV
|
13F-HR |
11/14/2023, 04:00 PM |
Q2 2023 |
5 |
$6.67B |
|
-$13.8M |
-$13.8M |
SGRY, DSEY, CERE, AVAH, ADV
|
13F-HR |
8/14/2023, 05:31 PM |
Q1 2023 |
5 |
$5.49B |
+$3.41M |
|
+$3.41M |
SGRY, DSEY, CERE, AVAH, ADV
|
13F-HR |
5/15/2023, 04:48 PM |
Q4 2022 |
5 |
$4.61B |
+$256M |
|
+$256M |
CERE, SGRY, DSEY, AVAH, ADV
|
13F-HR |
2/14/2023, 06:12 AM |
Q3 2022 |
5 |
$4.14B |
|
|
|
CERE, DSEY, SGRY, AVAH, ADV
|
13F-HR |
11/14/2022, 03:00 PM |
Q2 2022 |
5 |
$4.78B |
|
|
|
CERE, DSEY, SGRY, AVAH, ADV
|
13F-HR |
8/15/2022, 07:46 AM |
Q1 2022 |
5 |
$6.91B |
|
|
|
SGRY, CERE, DSEY, AVAH, ADV
|
13F-HR |
5/16/2022, 04:01 PM |
Q4 2021 |
5 |
$8.36B |
+$7.04M |
|
+$7.04M |
DSEY, SGRY, CERE, AVAH, ADV
|
13F-HR |
2/14/2022, 07:34 AM |
Q3 2021 |
6 |
$8.48B |
$0 |
-$4.01M |
-$4.01M |
DSEY, SGRY, CERE, AVAH, IQV
|
13F-HR |
11/15/2021, 04:08 PM |
Q2 2021 |
7 |
$10.2B |
+$2.51B |
-$1.16B |
+$1.35B |
DSEY, SGRY, CERE, AVAH, IQV
|
13F-HR |
8/16/2021, 04:23 PM |
Q1 2021 |
7 |
$6.8B |
+$3.48B |
-$30.9M |
+$3.45B |
DSEY, SGRY, MIK, CERE, IQV
|
13F-HR |
5/17/2021, 06:58 AM |
Q4 2020 |
7 |
$2.64B |
+$1.04B |
-$29.1M |
+$1.01B |
CERE, SGRY, MIK, IQV, ADV
|
13F-HR |
2/16/2021, 08:01 AM |
Q3 2020 |
5 |
$1.22B |
|
-$14.8M |
-$14.8M |
SGRY, MIK, IQV, VRTV, ATTO
|
13F-HR |
11/16/2020, 07:01 AM |
Q2 2020 |
5 |
$816M |
|
-$55.2M |
-$55.2M |
MIK, SGRY, IQV, VRTV, ATTO
|
13F-HR |
8/14/2020, 08:00 AM |
Q1 2020 |
5 |
$400M |
|
-$83.3M |
-$83.3M |
SGRY, MIK, IQV, ATTO, VRTV
|
13F-HR |
5/15/2020, 08:00 AM |
Q4 2019 |
5 |
$1.25B |
|
|
|
MIK, SGRY, IQV, ATTO, VRTV
|
13F-HR |
2/14/2020, 07:08 AM |
Q3 2019 |
6 |
$1.48B |
+$8.83M |
-$505M |
-$496M |
MIK, G, IQV, SGRY, VRTV
|
13F-HR |
11/14/2019, 07:36 AM |
Q2 2019 |
6 |
$2.07B |
|
-$324M |
-$324M |
G, MIK, IQV, SGRY, ATTO
|
13F-HR |
8/14/2019, 09:04 AM |
Q1 2019 |
7 |
$2.62B |
|
-$436M |
-$436M |
G, MIK, SGRY, IQV, ATTO
|
13F-HR |
5/15/2019, 09:00 AM |
Q4 2018 |
7 |
$2.72B |
|
-$98.1M |
-$98.1M |
G, MIK, IQV, SGRY, ATTO
|
13F-HR |
2/14/2019, 07:30 AM |
Q3 2018 |
7 |
$3.57B |
|
-$54.6M |
-$54.6M |
G, MIK, IQV, SGRY, ATTO
|
13F-HR |
11/14/2018, 05:46 AM |
Q2 2018 |
7 |
$3.53B |
|
-$158M |
-$158M |
G, MIK, SGRY, IQV, ATTO
|
13F-HR |
8/14/2018, 07:04 AM |
Q1 2018 |
7 |
$3.91B |
|
|
|
G, MIK, IQV, SGRY, ATTO
|
13F-HR |
5/15/2018, 07:23 AM |
Q4 2017 |
8 |
$4.51B |
+$529M |
-$782M |
-$253M |
G, MIK, IQV, ATTO, BFAM
|
13F-HR |
2/14/2018, 05:34 AM |
Q3 2017 |
10 |
$5.16B |
+$274M |
-$439M |
-$165M |
G, MIK, ATTO, BFAM, Q
|
13F-HR |
11/14/2017, 06:02 AM |
Q2 2017 |
10 |
$5.19B |
|
-$427M |
-$427M |
G, MIK, Q, ATTO, BFAM
|
13F-HR |
8/14/2017, 08:10 AM |
Q1 2017 |
10 |
$5.39B |
+$7.38K |
-$93.2M |
-$93.2M |
G, MIK, BFAM, Q, ATTO
|
13F-HR |
5/15/2017, 07:31 AM |
Q4 2016 |
10 |
$5.17B |
+$105M |
-$233M |
-$128M |
G, MIK, BFAM, Q, ATTO
|
13F-HR |
2/14/2017, 06:23 AM |
Q3 2016 |
9 |
$5.55B |
+$21.3M |
-$133M |
-$112M |
G, MIK, BFAM, Q, ATTO
|
13F-HR |
11/14/2016, 05:13 AM |
Q2 2016 |
11 |
$6.69B |
|
-$476M |
-$476M |
MIK, G, BFAM, TSEXXXX, Q
|
13F-HR |
8/15/2016, 08:21 AM |
Q1 2016 |
12 |
$7.1B |
+$1.77M |
-$720M |
-$718M |
MIK, G, BFAM, TSEXXXX, Q
|
13F-HR |
5/16/2016, 08:38 AM |
Q4 2015 |
11 |
$7.17B |
+$301M |
-$242M |
+$58.4M |
MIK, G, BFAM, TSEXXXX, Q
|
Restatement |
3/16/2016, 02:37 PM |
Q3 2015 |
10 |
$7.02B |
|
-$670M |
-$670M |
MIK, G, BFAM, TSEXXXX, Q
|
13F-HR |
11/13/2015, 05:40 AM |
Q2 2015 |
11 |
$9.02B |
|
-$401M |
-$401M |
MIK, BFAM, G, TSEXXXX, HDS
|
13F-HR |
8/14/2015, 09:59 AM |
Q1 2015 |
13 |
$9.99B |
+$419M |
-$327M |
+$91.2M |
MIK, G, BFAM, Q, HDS
|
13F-HR |
5/15/2015, 10:02 AM |
Q4 2014 |
13 |
$9.36B |
+$655M |
-$2.96B |
-$2.3B |
MIK, BFAM, G, Q, HDS
|
13F-HR |
2/17/2015, 08:06 PM |
Q3 2014 |
12 |
$9.97B |
+$1.82B |
|
+$1.82B |
BURL, BFAM, MIK, Q, HCA
|
13F-HR |
11/14/2014, 03:00 PM |
Q2 2014 |
11 |
$8.75B |
+$775M |
-$2.27B |
-$1.5B |
BFAM, BURL, Q, G, HCA
|
Restatement |
11/6/2014, 12:05 PM |
Q1 2014 |
11 |
$10.1B |
|
-$907M |
-$907M |
BURL, HCA, BFAM, STXXXX, G
|
13F-HR |
5/15/2014, 09:17 AM |
Q4 2013 |
11 |
$10.6B |
|
|
|
BURL, BFAM, HCA, BLMN, STXXXX
|
13F-HR |
2/10/2014, 03:52 PM |